Skip to main content
Premium Trial:

Request an Annual Quote

Gene Patent Case Presses On

The American Civil Liberties Union and the Public Patent Foundation are seeking a ruling from the US Supreme Court on the validity of gene patents, according to an ACLU statement. The plaintiffs are asking for redress from the high court in their case against Myriad Genetics' patents on the BRCA1 and BRCA2 genes, after a federal appeals court ruled in August that those patents were valid. According to our sister publication Pharmacogenomics Reporter, the Supreme Court could either choose to hear the case, or it could ask the Court of Appeals to reconsider its decision. A Myriad spokeswoman tells PGx Reporter the company is still considering its options, and that it has until December 15 to decide on its next steps.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.